Chemical and physical characteristics, building blocks, constitutive disaccharides, sulfation degree, and biological activities of heparins (UFHs) and of low molecular weight heparins (LMWHs) obtained by different depolymerization processes are examined comparatively in terms of structure characteristics, content of 1,6-anhydro rings, and other fingerprints. The heterogeneity of different LMWHs depends on different manufacturing processes and on particular Q1 specifications of pharmacopoeias. The reported examples prove that the variability among samples of LMWHs manufactured by the same process is quite limited. Most of the variability is derived from the parent UFH. In contrast, fingerprint groups and residues are specific to the depolymerization process and their extent can be roughly controlled through the process parameters. 
It is well known that the anticoagulant activity of heparin is dependent mainly on an antithrombin (AT) -binding domain that is present in only one third of the chains constituting heparins currently used in therapy, and that this domain is a specific pentasaccharide sequence. 1 Heparin chains are made up of various combinations of building blocks. 2 Different sulfation patterns are unevenly distributed along the heparin chains, with less-charged sequences mostly concentrated toward the reducing side of the chains and the mostcharged sequences concentrated toward the nonreducing side, with mixed N-acetylated (NA) and N-sulfated (NS) heparin domains between the two regions. The different proportion of the different domains and the actual composition within these domains of heparins vary, depending on the animal and organ source and also on the extraction and purification procedures. 3 All of the extraction processes include fractionation of heparin from related polysaccharides such as dermatan sulfate, chondroitin sulfates, and heparan sulfate, on anionic exchange resins. The European Pharmacopoeia and the ICH Q3 guideline Q5A prescribe the validation of manufacturing processes to demonstrate suitable inactivation or removal of any contamination by viruses or any other infectious agents. Some strong alkali treatments, designed for inactivation of viruses and other infectious agents, are currently used by heparin manufacturers. Meanwhile, the removal of proteins and/or nucleotides from unfractionated heparin (UFH) normally is obtained by acid treatments.
The purified and injectable heparin is always constituted by two families of polymers referred to (on the basis of their different electrophoretic mobility) as slow-moving heparin (SM-H) and fast-moving heparin (FM-H). 4 Significant structural differences were observed between SM-H and FM-H by 13 C-nuclear magnetic resonance (NMR) spectra, enzymatic degradation with heparinase and heparitinase from Flavobacterium heparinum, and significant differences in anti-Xa and anticoagulant activities also were found. 5 The relative percentages of FM-and SM-heparins are not constant even if heparins from the same origin are compared. As an example, different batches of heparin, all from pig mucosa, can show different reciprocal percentages of FM-H and SM-H depending on modulation of process parameters and peculiarities of the processes of extraction, fractionation, and purification. These last two steps may influence in different ways not only the percentages of structural building blocks, but also the different structural characteristics of the two families of heparins. Fig. 1 and Table 1 report the anti-factor Xa (aFXa) Q4 and activated partial thromboplastin time (aPTT) Q5 activities of porcine UFHs produced by different producers and probably by different processes. The aFXa activities vary from 149 to 238 IU/mg, the aPTT activities vary from 164 to 265 IU/mg; as a consequence, their aFXa/aPTT ratios vary between 0.78 and 1.21. The variability of the activities can be due to the different percentages of the two FM-H and SM-H families, the different percentage of constitutive disaccharide and oligosaccharide building blocks, or the possible structural modification caused by the processes of extraction, fractionation, and purification. The variability of biological activities is dependent largely on to the different content of high-affinity (HA) fractions containing an AT binding site characterized by the 3-O-sulfated monosaccharide GlcNSO 3 ,3SO 3 ,6SO 3 Q6 . Table 2 lists the molar percentages of major standard heparin disaccharides, the most representative and important tetrasaccharide containing 3-O-sulfated glucosamine, the building blocks containing unsaturated residue in tentative galacturonic form, and the total molar fractions of sulfated groups of UFHs extracted from porcine mucosa. These analyses have been performed by enzymatic attack with heparinases I, II, and III, and separation of fragments on SAX Q7 high-performance liquid chromatography according to the procedure of Mourier and Viskov. 6 Many oligosaccharides containing GlcNSO 3 , 3SO 3 have been identified and characterized also on the basis of their affinity for AT. 7 Probably not all the 3-Osulfated glucosamine-containing fragments are exclusive for the HA species. The presence of sequences containing GlcNSO 3 ,3SO 3 in no-affinity fractions (NAFs) has already been demonstrated by 1 H-NMR spectroscopy. 8 It is well known that not all the sequences of heparin can be completely recovered as disaccharides. The tetrasaccharide species containing the 3-O-sulfated glucosamine, defined as markers of the active site for AT, cannot be digested by heparinases. These and other building blocks, such as the linkage region GlcA(b1-3)Gal(b1-3) Gal(b1-4)Xyl(b1-O)-CH 2 -COOH, remain indigested, but they can be identified and quantificated. 6, 9 There are at least four tetrasaccharidic species containing the 3-O-sulfated glucosamine, obtained from the cleavage with heparinases and detected in intestinal porcine heparin:
SOME STRUCTURAL DIFFERENCES AND BIOLOGICAL ACTIONS OF UFH
ÁUÀGlcNAc; 6SÀGlcAÀGlcNS; 3S; 6S; ðÁIIaÀIIs glu Þ ÁUÀGlcNS; 6SÀGlcAÀGlcNS; 3S; 6S ðÁIIsÀIIs glu Þ ÁU2SÀGlcNS; 6SÀGlcAÀGlcNS; 3S; 6S ðÁIsÀIIs glu Þ ÁU2SÀGlcNAc; 6SÀGlcAÀGlcNS; 3S; 6S ðÁIaÀIIs glu Þ
The tetrasaccharide DU-GlcNAc,6S-GlcAGlcNS,3S,6S is the most represented. Like all the other tetrasaccharides, it represents less than 15% of the first one in the above list Q12 . 9 The variability observed among UFHs is evident for the trisulfated disaccharide DUA2S-GlcNS, 6S Q13 and for the different tetrasaccharides containing the sequence GlcNS,3S,6S. These differences are probably caused by the charge-fractionation step of deriving crude heparin from related substances, such as dermatan sulfate, chondroitin sulfates, and heparan sulfates, performed with specific but probably different concentrations of buffer. Under these conditions, the two SM and FM heparin families can be selected in a quantitatively and mutually different way. In fact, the disaccharidic composition of the two families of heparins clearly is different. Table 3 lists the disaccharide composition obtained 10 for the electrophoretically pure FM-H and SM-H fractions, 4 recovered by conventional methods from a preparation of UFH. The differences in sulfation degrees and the sulfated molar fractions are evident. The presence in UFHs of disaccharide DGalA-GlcNS,6S (Table 2) shows clear evidence of a alkaline treatment of the crude UFH designed for inactivation of viruses.
STRUCTURAL CHARACTERIZATION OF LOW MOLECULAR WEIGHT HEPARINS
The variability of the parent heparins is transferred, sometimes increased Q14 but rarely reduced, in the depolymerization products. Low molecular weight heparins (LMWHs) obtained by different depolymerization processes can be distinguished from each other mostly by particular specifications according to the pharmacopoeias (Table 4) . Specifically, they can be distinguished from each other by characteristic end-residues, which are easily identified and quantified by NMR spectroscopy. NMR spectroscopy characterizes major sulfation patterns as well as minor sequences such as the AT-binding sequence and the linkage region of LMWHs.
11 Artifacts associated with base-induced modifications such as the formation of iduronic acid epoxide and aziridine derivatives of N-sulfoglucosamine residues 12 can also be detected. Every depolymerization process impresses Q15 Q16 fingerprints to the resulting LMWH. For example, the alkaline hydrolysis of benzyl esters of heparin causes the concomitant cleavage of the polymer chain by b-elimination, but other side reactions also occur, which are known to affect heparin when it is submitted to base treatment. One of these side reactions is the inversion of configuration of a-L Q17 -iduronic-2-sulfate-acid (IdoA2SO 3 ) into a-L-galacturonic acid residues through the formation and opening of a C-2/C-3 epoxide. 12 The base-catalyzed C-2 epimerization of glucosamine N,6-disulfate (GlcNSO 3 ,6SO 3 ) residues at the reducing end of the chains with partial conversion to the diastereoisomer 2-deoxy-6-O-sulfo-2-sulfamino-D-mannose, is also expected, according to previous disclosures Q18 on the major unsaturated heparin disaccharide, 13 and on N-acetyl-glucosamine. 14 Possible formation of a bicyclic acetal between positions C-1 and C-6 of reducing glucosamine N,6-disulfate and a peeling reaction can also be predicted. These already disclosed 1,6-anhydro ring structures 15, 16 and the trisaccharide structure DIs-IdoA2SO 3 , arising as a consequence of peeling side reaction occurring during the alkaline hydrolysis of heparin benzyl ester, have been identified and characterized.
To evaluate the amount of the structural artifacts (or fingerprints) generated by the operative conditions, and the obtained LMWHs have been compared with the relevant parent UFHs. Data on three LMWHs obtained by alkaline hydrolysis of benzyl esters of three different UFHs are listed in Table 5 .
The distribution of the building blocks of LMWHs remained essentially unchanged and practically coincident with those of the parent UFHs. However, building blocks on which the fingerprints have been impressed Q22 superimpose on the major sequences. The content of trisulfated disaccharides DUA2S-GlcNS,6S, and, to a minor extent, of the disulfated disaccharide DUA-GlcNS,6S
Q23 , decreases in the LMWHs proportionally to the increase of 1,6-anhydro ring structures generated during the alkaline hydrolysis. Table 5 reports also the trisaccharide DUA2S-GlcNS,6S-IdoA2SO3, generated by a peeling reaction. Other building blocks, that is DUA2S-1,6-anhydroNS-
anhydro-2-deoxy-2-sulfaminob-D-glucopyranose]) and the tetrasaccharide DUA2S-GlcNS,6S-IdoA2S-1,6-anhydro mannosamine, 16 are bicyclic acetals, which, together with the two other disaccharides, DU-1,6-anhydro-2-deoxy-2-sulfaminob-D-glucopyranoside and DU-1,6-anhydro-2-deoxy-2-sulfaminoß-D-mannopyranoside, have been generated as result of the cyclization side reaction during the alkaline hydrolysis of benzyl esters of heparin. The contents of 1,6-anhydro ring structures have been determined according to the method disclosed by US2005/ 0119477, 16 and their structure has been confirmed also by NMR. 17 Furthermore, it has been demonstrated that the amounts of these 1,6-anhydro structures originated by this acetylization Q25 side reaction are in linear relationship with the temperature and with the reaction time of alkaline hydrolysis ( Fig. 2 and 3 ). As listed in Table 5 the SO 3 /COO ratios were not affected by the process. The total content of disaccharide sequences generating DGal-GlcNS and DGlcNS,6S unsaturated disaccharides was not reduced but rather increased. Similar results have been obtained in experiments not presented here.
Disaccharides DU-GlcNS,6R (R ¼ OH, OSO 3 -) have been detected and isolated according to the Mourier and Viskov's method 9 and the structure of DU-GlcNS,6S gal has been characterized by NMR spectroscopy. Proton and heteronuclear single quantum coherence spectra (not shown) indicated that the disaccharide is constituted by an unsaturated uronate residue a1-4 linked to an N,6-disulfated glucosamine. However, the small 3 J H1-H2 coupling/constant value (2.8 Hz) and the large 3 J H2-H3 value (7.7 Hz) measured for the unsaturated residue do not agree with coupling values measured for similar disaccharides in the a-GlcA and L-IdoA configuration, in which the unsaturated residue conformation is in equilibrium between the 1 H 2 and 2 H 1 forms. 18 We accordingly hypothesize that the unsaturated residue of the disaccharide was originated from a different uronic acid. The 1 H/ 1 H coupling constant values, the lack of H1-H3 NOE expected for structures in which the unsaturated residue is in the 2 H 1 form, the small 3 J H1-H2 and large 3 J H2-H3 values are compatible with a structure containing the unsaturated residue originated by a galacturonic acid in a prevalent 
Q20 Q21 Q25
1 H 2 conformation. Additional studies are needed to confirm this hypothesis. A trisaccharide containing an uronic acid 2-sulfate (UA2-SO 3 ) residue as the reducing sugar, arising from the reducing end of odd-numbered polysaccharide chains, has been detected in digests by heparinases of an experimental enoxaparin, according to the US2005/0119477 Q26 . 16 The product has been purified of digests by enrichment on semipreparative SAX-HPLC. The sample was also analyzed by liquid chromatography-mass spectroscopy (LC-MS) and NMR. The LC-MS chromatogram shows different ions with m/z assigned to alkaline adducts of tetrasulfated trisaccharide DU-GlcN-U and to desulfation products of the same trisaccharide. NMR analysis suggests the presence of an unsaturated 2-O-sulfated uronic acid at the nonreducing end, 1-4 a-linked 
CONCLUSIONS
LMWHs obtained by different depolymerization processes can be distinguished by characteristic end residues, by molecular weight profiles, by SO 3 -/COO -ratios, and by different markers. These differences may result in different biological activities. In these cases, a therapeutic nonequivalence due to the heterogeneity of the production processes is reasonably expected.
Different batches of LMWH obtained from the same depolymerization process can present variability that almost always is heritage of the characteristics Q28 of the parent UFH. If standardized and normalized parent UFHs are available, it would be possible to obtain batches of LMWH having limited and acceptable variability.
Q29
The fingerprints of different batches of LMWH obtained by the same chemical process do not cause heterogeneity, but only variability, most often insignificant from the therapeutic point of view. Moreover, the above fingerprints are dependent on the process parameters and can be controlled at will, as demonstrated by the examples shown here.
The main problem (i.e., the approval of generic LMWHs) is not the potential variability deriving from the same chemical process, but the need to conform Q30 the extraction and purification processes of UFH, and consequently, the characteristics of the parent heparins. Among the experimental samples of LMWH obtained by b-elimination of heparin benzyl ester, logical and expected relationships have always been observed. As an example, the content of the trisaccharide peeled structure always related to the total content of 1,6-anhydro structures; the formation of both of these structures is somehow related. This rough relationship is not surprising, given that the peeling reaction is due to alkali treatment at low to medium temperatures (i.e., about the same conditions that cause the formation of the 1,6-anhydro ring).
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We thank Professor Casu for its critical comments of this manuscript and helpful suggestions, and Dr. G. Torri and Dr. M. Guerrini for the NMR characterization of some of the products. carbohydrates and amino acids have been changed to "D" and "l" (small capital letters) throughout. Q18: AU: Please clarify "previous disclosures" and "already disclosed" (in the last sentece of this paragraph). Do you mean "previous studies" and "recently described," respectively? Q19 Thurlbeck's cornerstone textbook and reference on pulmonary pathology returns in a brand new edition! Updated with the latest advances in the field, you will save time with all-inclusive coverage of neoplastic, non-neoplastic, infectious, occupational/environmental, and developmental pathologies in one book, learn how molecular biology provides a greater understanding of lung development, gain new insights into the diagnosis of neoplastic and non-neoplastic lung disease, find pertinent information on clinical features, epidemiology, and pathogenetic mechanisms of lung disease and much more! Comprehensive in its scope and authoritative in its scholarship, Thurlbeck's Pathology of the Lung is a virtual one-volume encyclopedia written by a ''who's who'' list of specialists. It is the one text that no pathologist, pulmonologist, or resident in either specialty can afford to be without. 
